SCD1 inhibitor-4
≥98%
- Product Code: 107335
CAS:
1295541-87-5
| Molecular Weight: | 363.34 g./mol | Molecular Formula: | C₁₇H₁₆F₃N₅O |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C, sealed, dry |
Product Description:
SCD1 inhibitor-4 is primarily used in research and therapeutic applications targeting metabolic disorders and cancer. It works by inhibiting stearoyl-CoA desaturase-1 (SCD1), an enzyme involved in fatty acid metabolism. This inhibition can reduce the synthesis of monounsaturated fatty acids, which are implicated in insulin resistance, obesity, and tumor growth. In cancer studies, it has shown potential in suppressing tumor progression by disrupting lipid metabolism in cancer cells. Additionally, it is being explored for its role in managing metabolic syndromes, such as diabetes and non-alcoholic fatty liver disease, by improving insulin sensitivity and reducing lipid accumulation. Its application in preclinical models provides insights into its efficacy and safety for future therapeutic development.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | $485.89 |
+
-
|
| 0.025 | 10-20 days | $1,607.17 |
+
-
|
| 0.100 | 10-20 days | $4,111.37 |
+
-
|
SCD1 inhibitor-4
SCD1 inhibitor-4 is primarily used in research and therapeutic applications targeting metabolic disorders and cancer. It works by inhibiting stearoyl-CoA desaturase-1 (SCD1), an enzyme involved in fatty acid metabolism. This inhibition can reduce the synthesis of monounsaturated fatty acids, which are implicated in insulin resistance, obesity, and tumor growth. In cancer studies, it has shown potential in suppressing tumor progression by disrupting lipid metabolism in cancer cells. Additionally, it is being explored for its role in managing metabolic syndromes, such as diabetes and non-alcoholic fatty liver disease, by improving insulin sensitivity and reducing lipid accumulation. Its application in preclinical models provides insights into its efficacy and safety for future therapeutic development.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :